Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213154 · ClinicalTrials.gov registry record · NA
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
A NA study of Skin Neoplasm and Malignant Skin Neoplasm, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT07213154: Recruiting NA study of Skin Neoplasm and Malignant Skin Neoplasm, sponsored by Emory University.
NCT07213154 is a NA study of Skin Neoplasm and Malignant Skin Neoplasm that is actively recruiting participants, run by Emory University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07213154, a NA study of Skin Neoplasm and Malignant Skin Neoplasm, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
Primary Outcome
Assessing the application of quantitative oblique back-illumination microscopy (qOBM) to assess skin pathology. Analysis will be descriptive in nature (e.g., appearance of cells in the epidermis, dermis, and basal junction). Quantitative analysis will include extracting image features such as mean, standard deviation, and kurtosis of the phase values; entropy, fractal dimension, gray level co-occurrence matrix, and other mathematical image features. Radiation Therapy Oncology Group (RTOG) Acute
Conditions Studied
Interventions
- RADIATION Radiation Therapy
- PROCEDURE Quantitative Oblique Back-Illumination Microscopy
Study Locations (2)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2027-09-17 |
| Phase | NA |
What NCT07213154 shows while recruiting
NCT07213154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Skin Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Radiation Therapy is the first listed.
NCT07213154 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07213154 about?
NCT07213154 is a clinical study titled "Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions". This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging proce...
What is the current status of trial NCT07213154?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-15. Estimated completion is 2027-09-17.
What conditions does trial NCT07213154 study?
This clinical trial studies the following conditions: Skin Neoplasm, Malignant Skin Neoplasm, Skin Disorder.
What interventions are being tested in trial NCT07213154?
The interventions under investigation include: Radiation Therapy (RADIATION), Quantitative Oblique Back-Illumination Microscopy (PROCEDURE).
Who is sponsoring clinical trial NCT07213154?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213154 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07213154's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI